Breast Cancer 21 Gene Test is necessary.
The Breast Cancer 21 Gene Test is mainly designed to provide effective targeted treatment options by detecting 21 different oncogenes in breast cancer cells, and can also predict the 10-year risk of breast cancer recurrence.
The test detects the expression of a set of specific genes in malignant breast cancer tumor tissues, which helps to predict the prognosis of breast cancer, the risk of recurrence and tumor metastasis, and guides the development of individualized treatment plans.
Therefore, breast cancer 21 gene test is necessary. Especially for female patients who have already suffered from breast cancer or have a family history of breast cancer, such genes should be tested as soon as possible.